Secreted phospholipases A2 are differentially expressed and epigenetically silenced in human breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 445, Issue 1, 2014, Pages 230-235

  Brglez, Vesna ^a   Pucer, Anja ^a   Pungerčar, Jože ^a   Lambeau, Gérard ^b   Petan, Toni ^a  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Breast cancer; DNA methylation; Epigenetics; Histone acetylation; Lipid signalling

Indexed keywords

HISTONE; MESSENGER RNA; PHOSPHOLIPASE A2; RETINOIC ACID RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; EPIGENETICS; FLUOROIMMUNOASSAY; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; TRANSCRIPTION INITIATION SITE;

BREAST CANCER; DNA METHYLATION; EPIGENETICS; HISTONE ACETYLATION; LIPID SIGNALLING; SECRETED PHOSPHOLIPASE A(2);

AZACITIDINE; BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GROUP II PHOSPHOLIPASES A2; GROUP III PHOSPHOLIPASES A2; GROUP X PHOSPHOLIPASES A2; HUMANS; HYDROXAMIC ACIDS; MCF-7 CELLS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84896695742     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.01.182     Document Type: Article

References (24)

1. M.A. Dawson, and T. Kouzarides Cancer epigenetics: from mechanism to therapy Cell 150 2012 12 27
2. R. Connolly, and V. Stearns Epigenetics as a therapeutic target in breast cancer J. Mammary Gland Biol. Neoplasia 17 2012 191 204
3. G. Lambeau, and M.H. Gelb Biochemistry and physiology of mammalian secreted phospholipases A2 Annu. Rev. Biochem. 77 2008 495 520
4. M. Murakami, and G. Lambeau Emerging roles of secreted phospholipase A2 enzymes: an update Biochimie 95 2013 43 50
5. K.F. Scott, M. Sajinovic, and J. Hein et al. Emerging roles for phospholipase A2 enzymes in cancer Biochimie 92 2010 601 610
6. Y. Morioka, M. Ikeda, and A. Saiga et al. Potential role of group X secretory phospholipase A2 in cyclooxygenase-2-dependent PGE2 formation during colon tumorigenesis FEBS Lett. 487 2000 262 266
7. F. Surrel, I. Jemel, and E. Boilard et al. Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators Mol. Pharmacol. 76 2009 778 790
8. F. Mannello, W. Qin, and W. Zhu et al. Nipple aspirate fluids from women with breast cancer contain increased levels of group IIa secretory phospholipase A2 Breast Cancer Res. Treat. 111 2008 209 218
9. S. Yamashita, J. Yamashita, and M. Ogawa Overexpression of group II phospholipase A2 in human breast cancer tissues is closely associated with their malignant potency Br. J. Cancer 69 1994 1166 1170
10. A. Pucer, V. Brglez, and C. Payré et al. Group X secreted phospholipase A2 induces lipid droplet formation and prolongs breast cancer cell survival Mol. Cancer 12 2013 e111
11. D.R. Rhodes, S. Kalyana-Sundaram, and V. Mahavisno et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles Neoplasia 9 2007 166 180
12. L.C. Li, and R. Dahiya MethPrimer: designing primers for methylation PCRs Bioinformatics 18 2002 1427 1431
13. R.M. Neve, K. Chin, and J. Fridlyand et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes Cancer Cell 10 2006 515 527
14. K. Ganesan, T. Ivanova, and Y. Wu et al. Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene Cancer Res. 68 2008 4277 4286
15. M. Menschikowski, A. Hagelgans, and H. Kostka et al. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells Neoplasia 10 2008 1195 1203
16. M. Menschikowski, A. Hagelgans, and E. Gussakovsky et al. Differential expression of secretory phospholipases A2 in normal and malignant prostate cell lines: regulation by cytokines, cell signaling pathways, and epigenetic mechanisms Neoplasia 10 2008 279 286
17. D.I. Rodenhiser, J. Andrews, and W. Kennette et al. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays Breast Cancer Res. 10 2008 R62
18. H.H. Nelson, C.J. Marsit, and B.C. Christensen et al. Key epigenetic changes associated with lung cancer development: results from dense methylation array profiling Epigenetics 7 2012 559 566
19. C. Grimm, L. Chavez, and M. Vilardell et al. DNA-methylome analysis of mouse intestinal adenoma identifies a tumour-specific signature that is partly conserved in human colon cancer PLoS Genet. 9 2013 e1003250
20. Y. Miki, S. Mukae, and M. Murakami et al. Butyrate inhibits oral cancer cell proliferation and regulates expression of secretory phospholipase A2-X and COX-2 Anticancer Res. 27 2007 1493 1502
21. S. Claerhout, J.Y. Lim, and W. Choi et al. Gene expression signature analysis identifies vorinostat as a candidate therapy for gastric cancer PLoS One 6 2011 e24662
22. C.S. Ward, P. Eriksson, and J.L. Izquierdo-Garcia et al. HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells PLoS One 8 2013 e62610
23. R.J. Fijneman, J.R. Peham, and M.A. van de Wiel et al. Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice Cancer Sci. 99 2008 2113 2119
24. G.S. Belinsky, T.V. Rajan, and E.A. Saria et al. Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth Mol. Carcinog. 46 2007 106 116